DEVELOPMENT AND IN VIVO EVALUATION OF ABACAVIR SULPHATE MUCOADHESIVE BUCCAL FILMS

Authors

  • MADHURI P. Department of Pharmaceutics, GITAM School of Pharmacy, Rishikonda, Visakhapatnam-530045, Andhra Pradesh, India
  • RADHA G. V. Department of Pharmaceutics, GITAM School of Pharmacy, Rishikonda, Visakhapatnam-530045, Andhra Pradesh, India

DOI:

https://doi.org/10.22159/ijap.2024v16i1.49765

Keywords:

Abacavir sulphate, Mucoadhesion, Buccal films, Prolonged release, Pharmacokinetics

Abstract

Objective: The objective of the study was to evaluate the pharmacokinetic parameters of abacavir sulphate mucoadhesive buccal films in vivo.

Methods: Abacavir sulphate mucoadhesive buccal films were developed using the solvent casting method and the prepared buccal films were evaluated for qualitative and quantitative parameters. Pharmacokinetic parameters (maximum plasma concentration [Cmax], maximum plasma concentration [Tmax], area under the curve [AUC], and biological half-life [t1/2]) were evaluated in vivo using healthy albino white rabbits. The blood samples were collected evaluated and the results were compared with Ziagen a reference standard. The Modern Version 6 software and the pharmacokinetic function (Microsoft Excel add-in) applications were used to conduct the statistical study.

Results: The abacavir sulphate mucoadhesive buccal films were prepared successfully and the evaluated qualitative and quantitative parameters were within in the acceptable range. The results of the study stated that Cmax, Tmax, AUC0-t, AUC0-α, and t1/2 of abacavir sulphate mucoadhesive buccal film were found to be 93.86 ng/ml, 8 h, 1652.21 ng/ml×h, 2939.76 ng/ml×h, and 17.96 h, respectively. These results were comparable with the reference standard.

Conclusion: The overall absorption of abacavir sulphate was more in the test formulation with respect to the reference product at the same dose. Hence the study concludes that abacavir sulphate mucoadhesive buccal films achieved prolonged muchoadhesion and improved bioavailability compared to the conventional formulation.

Downloads

Download data is not yet available.

References

Abbas IK, Rajab NA, Hussein AA. Formulation and in vitro evaluation of darifenacin hydrobromide as buccal films. Iraqi J Pharm Sci. 2019 Dec;28(2):83-94. doi: 10.31351/vol28iss2pp83-94.

Matsyagiri L, Bhavani CH. Effect of polymers and diluents on mucoadhesive bilayered buccal tablets of ondansetron HCl. J Emerg Technol Innov Res. 2022 Jun;9(6):h83-93.

Hanif M, Zaman M, Chaurasiya V. Polymers used in buccal film: a review. Des Monomers Polym. 2015 Sep;18(2):105-11. doi: 10.1080/15685551.2014.971389.

Abikesh PK, Mahapatra S, Nagvenkar P, Gude R. Formulation and physicochemical characterization of buccal mucoadhesive films containing alfuzosin hydrochloride. J Adv PharmSci. 2020 Mar;22(2):9-20.

LA. Buccal drug delivery system: history and recent developments. Asian J Pharm Clin Res. 2016 Jul;9(6):36-42. doi: 10.22159/ajpcr.2016.v9i6.14041.

Abouhussein D, El Nabarawi MA, Shalaby SH, El-Bary AA. Cetylpyridinium chloride chitosan blended mucoadhesive buccal films for treatment of pediatric oral diseases. J Drug Deliv Sci Technol. 2020 Mar;57(4):1-9. doi: 10.1016/j.jddst.2020.101676.

Ammanage A, Rodriques P, Kempwade A, Hiremath R. Formulation and evaluation of buccal films of piroxicam co-crystals. Future J Pharm Sci. 2020 May;16(6):1-11.

Puri V, Sharma A, Kumar P, Singh I. Thiolation of biopolymers for developing drug delivery systems with enhanced mechanical and mucoadhesive properties: a review. Polymers. 2020 Aug;12(8):1803. doi: 10.3390/polym12081803, PMID 32796741.

Kempwade A, Ammanage A, Rodriques P, Hiremath R. Formulation and evaluation of buccal films of piroxicam co-crystals. Future J Pharm Sci. 2020 May;16(6):1-11.

Saag MS, Sonnerborg A, Torres RA, Lancaster D, Gazzard BG, Schooley RT. Antiretroviral effect and safety of abacavir alone and in combination with zidovudine in HIV-infected adults. Abacavir Phase 2 Clinical Team. 1998 Nov;12(16):F203-9. doi: 10.1097/00002030-199816000-00002, PMID 9833848.

Gray LR, Tachedjian G, Ellett AM, Roche MJ, Cheng WJ, Guillemin GJ. The NRTIs lamivudine, stavudine and zidovudine have reduced HIV-1 inhibitory activity in astrocytes. PLOS ONE. 2013 Apr;8(4):e62196. doi: 10.1371/journal.pone.0062196, PMID 23614033.

Al-Dhubiab BE, Nair AB, Kumria R, Attimarad M, Harsha S. Development and evaluation of buccal films impregnated with selegiline-loaded nanospheres. Drug Deliv. 2016 Sep;23(7):2154-62. doi: 10.3109/10717544.2014.948644, PMID 25182182.

Madhuri P, Gadela RV. Formulation and evaluation of mucoadhesive buccal films of abacavir sulphate. NeuroQuantology. 2020 Sep;18(9):146-59.

Di Prima G, Conigliaro A, De Caro V. Mucoadhesive polymeric films to enhance barbaloin penetration into buccal mucosa: a novel approach to chemoprevention. AAPS PharmSciTech. 2019 Jan;20(1):18. doi: 10.1208/s12249-018-1202-1, PMID 30603884.

Winarti L, Laksono BT, Sari LORK. Optimization of hydroxy propyl methyl cellulose and carbomer in diltiazem hydrochloride mucoadhesive buccal film. Indonesian J Pharm. 2021 Jan;32(1):43-51. doi: 10.22146/ijp.995.

Maharjan M, Baby B, Sankhi S, Anusha BVS, Shrestha S, Marasine NR. Development and optimization of mucoadhesive films for enhanced drug delivery in treatment of lichen planus. Nep J Health Sci. 2021;1(1):29-36. doi: 10.3126/njhs.v1i1.38724.

Nair AB, Al-Dhubiab BE, Shah J, Jacob S, Saraiya V, Attimarad M. Mucoadhesive buccal film of almotriptan improved therapeutic delivery in rabbit model. Saudi Pharm J. 2020 Feb;28(2):201-9. doi: 10.1016/j.jsps.2019.11.022, PMID 32042259.

Haju SS, Yadav S. Formulation and evaluation of cilnidipine mucoadhesive buccal film by solvent casting technique for the treatment of hypertension. Int J Pharm Pharm Sci. 2020 Sep;13(9):34-43. doi: 10.22159/ijpps.2021v13i9.42641.

Siddique W, Sarfraz RM, Zaman M, Butt MH, Hayat Z, Gul M. Impact of polymer and plasticizer on mechanical properties of film: a quality by design approach. Lat Am J Pharm. 2021 Dec;40(12):3002-8.

Jose P, Paarakh P, Setty CM, Christoper GV. Release kinetics–concepts and applications. Int J Pharm Technol. 2018 Aug;8:12-20.

Nair AB, Shah J, Jacob S, Al-Dhubiab BE, Patel V, Sreeharsha N. Development of mucoadhesive buccal film for rizatriptan: in vitro and in vivo evaluation. Pharmaceutics. 2021 May;13(5):728. doi: 10.3390/pharmaceutics13050728, PMID 34063402.

Haju SS, Yadav S. Formulation and evaluation of cilnidipine mucoadhesive buccal film by solvent casting technique for the treatment of hypertension. Int J Pharm Pharm Sci. 2021 Sep;13(9):34-43. doi: 10.22159/ijpps.2021v13i9.42641.

Hyma P, Fatima S. Formulation and evaluation of oral fast dissolving films of naproxen sodium. Int J Curr Pharm Res. 2022 Mar;14(2):48-53.

Prakash A, Soni PK, Paswan SK, Saini TR. Formulation and optimization of mucoadhesive buccal film for nicotine replacement therapy. Int J App Pharm. 2023 Mar;15(3):100-12. doi: 10.22159/ijap.2023v15i3.47412.

Published

07-01-2024

How to Cite

P., M., & G. V., R. (2024). DEVELOPMENT AND IN VIVO EVALUATION OF ABACAVIR SULPHATE MUCOADHESIVE BUCCAL FILMS. International Journal of Applied Pharmaceutics, 16(1), 161–165. https://doi.org/10.22159/ijap.2024v16i1.49765

Issue

Section

Original Article(s)